FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015293407> ?p ?o ?g. }

• W3015293407 endingPage "9" @default.
• W3015293407 startingPage "1" @default.
• W3015293407 abstract "The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (ANCA-) associated vasculitis (AAV) disease activity.We evaluated 90 AAV patients with follow-up data and 35 normal controls; their plasma suPAR and C-reactive protein (CRP) levels were measured by ELISA. Associations between these levels, clinical parameters, and prognosis were analyzed.Plasma suPAR levels in AAV patients were significantly higher than in healthy controls (5,920.08 ± 3,447.17 vs. 1,441.97 ± 835.04 pg/mL, P < 0.001). Furthermore, suPAR was significantly elevated in AAV patients in active stage compared to those in partial remissions (6,492.19 ± 3,689.48 vs. 5,031.86 ± 2,489.01 pg/mL, P = 0.039). Correlation analyses demonstrated that suPAR levels positively correlated with initial serum creatinine, BVAS, CRP, and procalcitonin concentration, and negatively correlated with eGFR and C3 circulating levels. In a Kaplan-Meier survival analysis, patients with plasma suPAR levels >5683.3 pg/mL showed poorer survival than patients with lower levels (log-rank, P = 0.001). Besides, multivariate analyses confirmed that plasma suPAR levels were an independent adverse prognostic factor for a composite outcome of end-stage renal disease (ESRD) or death, after adjusting for age and gender (HR 1.05, 95% CI = 1.01 - 1.11, P = 0.043). Receiver operating characteristic curves showed a suPAR cutoff value >6662.2 pg/mL for composite outcome with 68% sensitivity and 88% specificity, with an AUC = 0.82, (95% CI = 0.68 - 0.96, P < 0.001).Circulating suPAR levels might be a marker of activity correlated with disease activity in AAV patients, and, to some extent, could be a factor of poor prognosis." @default.
• W3015293407 created "2020-04-17" @default.
• W3015293407 creator A5024928115 @default.
• W3015293407 creator A5047624204 @default.
• W3015293407 creator A5050756282 @default.
• W3015293407 creator A5055650711 @default.
• W3015293407 creator A5057435733 @default.
• W3015293407 creator A5073896543 @default.
• W3015293407 date "2020-04-07" @default.
• W3015293407 modified "2023-09-27" @default.
• W3015293407 title "The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis" @default.
• W3015293407 cites W1929087872 @default.
• W3015293407 cites W1974471520 @default.
• W3015293407 cites W1974551119 @default.
• W3015293407 cites W1988777224 @default.
• W3015293407 cites W1997506248 @default.
• W3015293407 cites W1998022070 @default.
• W3015293407 cites W2012080977 @default.
• W3015293407 cites W2012599298 @default.
• W3015293407 cites W2028240508 @default.
• W3015293407 cites W2031147426 @default.
• W3015293407 cites W2031517139 @default.
• W3015293407 cites W2033142539 @default.
• W3015293407 cites W2038049790 @default.
• W3015293407 cites W2043754323 @default.
• W3015293407 cites W2043859733 @default.
• W3015293407 cites W2046208640 @default.
• W3015293407 cites W2048718481 @default.
• W3015293407 cites W2056753520 @default.
• W3015293407 cites W2059752046 @default.
• W3015293407 cites W2067555367 @default.
• W3015293407 cites W2081911468 @default.
• W3015293407 cites W2082322877 @default.
• W3015293407 cites W2093887619 @default.
• W3015293407 cites W2100588516 @default.
• W3015293407 cites W2103966175 @default.
• W3015293407 cites W2121293076 @default.
• W3015293407 cites W2122595921 @default.
• W3015293407 cites W2124107576 @default.
• W3015293407 cites W2128121047 @default.
• W3015293407 cites W2140733306 @default.
• W3015293407 cites W2141590063 @default.
• W3015293407 cites W2142895007 @default.
• W3015293407 cites W2154159325 @default.
• W3015293407 cites W2155343924 @default.
• W3015293407 cites W2155965977 @default.
• W3015293407 cites W2160998020 @default.
• W3015293407 cites W2162051944 @default.
• W3015293407 cites W2167903465 @default.
• W3015293407 cites W2169437650 @default.
• W3015293407 cites W2186539424 @default.
• W3015293407 cites W2195506720 @default.
• W3015293407 cites W2260844430 @default.
• W3015293407 cites W2317111303 @default.
• W3015293407 cites W2406575963 @default.
• W3015293407 cites W2556390094 @default.
• W3015293407 cites W2607031541 @default.
• W3015293407 cites W2762569576 @default.
• W3015293407 cites W2798105113 @default.
• W3015293407 cites W4246798637 @default.
• W3015293407 doi "https://doi.org/10.1155/2020/7850179" @default.
• W3015293407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7166284" @default.
• W3015293407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32322165" @default.
• W3015293407 hasPublicationYear "2020" @default.
• W3015293407 type Work @default.
• W3015293407 sameAs 3015293407 @default.
• W3015293407 citedByCount "6" @default.
• W3015293407 countsByYear W30152934072021 @default.
• W3015293407 countsByYear W30152934072022 @default.
• W3015293407 countsByYear W30152934072023 @default.
• W3015293407 crossrefType "journal-article" @default.
• W3015293407 hasAuthorship W3015293407A5024928115 @default.
• W3015293407 hasAuthorship W3015293407A5047624204 @default.
• W3015293407 hasAuthorship W3015293407A5050756282 @default.
• W3015293407 hasAuthorship W3015293407A5055650711 @default.
• W3015293407 hasAuthorship W3015293407A5057435733 @default.
• W3015293407 hasAuthorship W3015293407A5073896543 @default.
• W3015293407 hasBestOaLocation W30152934071 @default.
• W3015293407 hasConcept C126322002 @default.
• W3015293407 hasConcept C159641895 @default.
• W3015293407 hasConcept C203014093 @default.
• W3015293407 hasConcept C2776929539 @default.
• W3015293407 hasConcept C2779679481 @default.
• W3015293407 hasConcept C2780306776 @default.
• W3015293407 hasConcept C56219504 @default.
• W3015293407 hasConcept C71924100 @default.
• W3015293407 hasConcept C90924648 @default.
• W3015293407 hasConceptScore W3015293407C126322002 @default.
• W3015293407 hasConceptScore W3015293407C159641895 @default.
• W3015293407 hasConceptScore W3015293407C203014093 @default.
• W3015293407 hasConceptScore W3015293407C2776929539 @default.
• W3015293407 hasConceptScore W3015293407C2779679481 @default.
• W3015293407 hasConceptScore W3015293407C2780306776 @default.
• W3015293407 hasConceptScore W3015293407C56219504 @default.
• W3015293407 hasConceptScore W3015293407C71924100 @default.
• W3015293407 hasConceptScore W3015293407C90924648 @default.
• W3015293407 hasFunder F4320321001 @default.
• W3015293407 hasLocation W30152934071 @default.

• next